Work

A Risk-Benefit Assessment of Drugs Used in the Management of Obsessive-Compulsive Disorder

Year: 1996

Type: article

Source: Drug Safety

DOI: 10.2165/00002018-199615020-00004

Authors: Linda L. Carpenter, Christopher J. McDougle, C. Neill Epperson, Lawrence H. Price

Institutions: Yale University, Connecticut Mental Health Center

Language: English

Topic: Obsessive-Compulsive Spectrum Disorders

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Yale University, National Institutes of Health, National Institute of Mental Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G306157304, G3210117988, PATHOGENESIS &TREATMENT OF TS, OCD &RELATED DISORDERS, G4220198355, NEUROBIOLOGICAL BASIS OF MAJOR PSYCHIATRIC DISORDERS, Austism and Related Disorders: Development and Outcome

OpenAlex ID: W2004088832

FWCI: 2.109

Cites: 148

Cited by: 16

Related to: 10